Shanghai Kaibao Company is mainly engaged in the research, development, production and sales of Tanreqing injection, a Chinese patent medicine for clearing away heat and toxic materials. Tanreqing injection, the leading product, has the effects of clearing away heat and toxic materials, resolving phlegm and relieving spasm, has a unique antiviral effect, and has inhibitory effects on Streptococcus pneumoniae, Haemophilus influenzae, Streptococcus hemolyticus B and Staphylococcus aureus. It is mainly used for treating early pneumonia, acute bronchitis, acute attack of chronic bronchitis and upper respiratory tract infection. Tanreqing injection is a national patent product and a second-class new Chinese medicine.
Zhejiang Pharmaceutical Company is a leading pharmaceutical enterprise in Zhejiang Province and an important production base of raw materials and preparations in China. A product production system featuring fluoroquinolones, vitamins and antibiotics has been formed, and an industrial pattern integrating R&D, production and sales has been formed.
Livzon Group is a well-known large-scale comprehensive high-tech pharmaceutical enterprise in China, with more than 400 kinds of products, which has outstanding leading advantages in three major fields: digestive tract drugs, cardiovascular and cerebrovascular drugs and anti-infective drugs.